NovaPeptide
NovaPeptide's Purity focus record is strongest on Retatrutide, with repeated high-purity identity passes and fills close to target across the observed lots. Evidence is narrow rather than dispersed: only Retatrutide is rated, and thin batch documentation keeps the otherwise recent clean streak evidence-limited.
Two sister domains tell conflicting China-manufacturer and Delaware-biotech stories, while registry and WHOIS records point elsewhere. The report traces the virtual-office address, informal payment rails, and copycat coupon-page confusion buyers must verify.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including NovaPeptide rows.
Cancel anytime
| Date | Result | Test | Lab | Purity | Dosage | Label | COA |
|---|---|---|---|---|---|---|---|
| 18 Aug 2026 | Pass | Retatrutide NovaPeptide | lab name | View COA | |||
| 18 Aug 2026 | Pass | Retatrutide NovaPeptide | lab name | View COA | |||
| 28 Apr 2026 | Pass | Retatrutide NovaPeptide | lab name | View COA | |||
| 26 Apr 2026 | Pass | Retatrutide NovaPeptide | lab name | View COA | |||
| 19 Mar 2026 | Pass | Retatrutide NovaPeptide | lab name | View COA | |||
| 19 Mar 2026 | Pass | Retatrutide NovaPeptide | lab name | View COA | |||
About NovaPeptide test results from Finnrick
NovaPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 1 peptide and 6 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible NovaPeptide peptides in this dataset are BPC-157 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 6 recent tests.